• Over 110,000 people with anomalies requiring clarification detected through early eye screening

• More than 3,500 people with urgent medical treatment needs identified

• Over 800 partner opticians enable low-barrier access to early detection

Munich, 01.06.2026

Ocumeda, together with its partner opticians, has performed more than 500,000 eye check-ups, reaching an important milestone in eye screening. The results impressively underline the contribution that early and low-threshold screenings can make to preserving vision.

In almost every fourth person examined, anomalies were detected – in total in more than 110,000 people. In more than 3,500 cases, there was an acute need for action: anomalies were identified that required urgent ophthalmological consultation and treatment, such as vascular occlusions, retinal detachments, or even malignant tumors. The Ocumeda team proactively supported these customers in directing them to medical care.

At the same time, the data shows the high demand for more accessible eye screening: for over 88% of the participants, the last visit to the ophthalmologist was more than two years ago. 63% of them had not visited an ophthalmologist's office for over five years, or even never.

"500,000 eye check-ups show what a difference close cooperation between optics and medicine can make for the early detection of eye diseases," says Dr. Benedikt Wiechers, Managing Director and Founder of Ocumeda. "Together with our partner opticians, we create low-barrier access to eye screening and reach people much earlier – often before they even perceive any symptoms themselves. The fact that we have already been able to identify thousands of people with urgent medical needs and guide them specifically to the right care shows the social and medical added value of our care approach. It makes me proud to see how we contribute to preventing avoidable vision loss through interdisciplinary collaboration."

The Ocumeda eye check-up is based on a hybrid care approach: Specially trained opticians perform measurements directly in the optical store using modern equipment. The collected data is then evaluated digitally by a network of ophthalmologists. Customers receive the medical report with individual recommendations for action the next day. In case of anomalies, Ocumeda supports those affected with further ophthalmological consultation.

This access to early detection is made possible by a network of now more than 800 affiliated opticians in Germany, Austria, and Switzerland. These include well-known partners such as Fielmann, Zeiss, DELKER Optik, Neusehland, Binder Optik, 1-2-3 Brille, the LoQu Group, and many others. Together, they bring eye screening to where people regularly have their vision checked anyway – accessible, uncomplicated, and integrated into everyday life.

ABOUT OCUMEDA  
Ocumeda is one of the leading tele-ophthalmology platforms in Europe. Ocumeda’s mission is to prevent vision loss and blindness in millions of people. The company was founded by an interdisclipinary team around renowned Swiss ophthalmologists who were repeatedly confronted with patients whose serious eye diseases were often diagnosed too late – with the result that vision loss could no longer be prevented. This observation was the catalyst for the founding of Ocumeda, with the goal of making eye screening accessible to everyone. To date, Ocumeda has already examined over 500,000 people and has a network of more than 800 optical specialty stores and ophthalmologists.